TARS
Tarsus Pharmaceuticals Inc
76.00$
+2.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.06 | 0.41 | 0.78 | 1.08 | 1.25 | 1.72 | 1.99 | 2.42 | 2.79 | 3.54 | 3.77 | 4.01 | 13.97 | |
| 0.01 | 0.04 | 0.05 | 0.08 | 0.08 | 0.13 | 0.13 | 0.15 | 0.58 | 0.26 | 0.22 | 0.28 | 1.31 | |
| 0.05 | 0.37 | 0.74 | 1.00 | 1.17 | 1.59 | 1.86 | 2.28 | 2.21 | 3.29 | 3.55 | 3.73 | 12.66 | |
| 0.40 | 0.42 | 0.34 | 0.33 | 0.32 | 0.44 | 0.37 | 0.37 | 0.38 | 0.42 | 0.52 | 0.71 | 2.02 | |
| 0.99 | 2.06 | 1.46 | 1.55 | 1.51 | 1.79 | 2.16 | 2.43 | 2.55 | 3.05 | 3.18 | 3.47 | 12.13 | |
| 1.39 | 1.76 | 1.80 | 1.88 | 1.82 | 2.23 | 2.53 | 2.80 | 2.55 | 3.48 | 3.70 | 4.19 | 13.78 | |
| -1.34 | -1.39 | -1.07 | -0.88 | -0.66 | -0.63 | -0.67 | -0.52 | -0.34 | -0.19 | -0.14 | -0.46 | -1.12 | |
| 0.03 | 0.03 | 0.03 | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.20 | |
| -1.28 | -1.31 | -1.01 | -0.88 | -0.61 | -0.60 | -0.64 | -0.48 | -0.30 | -0.15 | -0.22 | -0.36 | -1.02 | |
| -0.06 | 0.95 | -0.01 | – | – | – | – | – | – | 0.05 | -0.05 | 0.06 | – | |
| -1.28 | -1.31 | -1.01 | -0.88 | -0.61 | -0.60 | -0.64 | -0.48 | -0.30 | -0.20 | -0.16 | -0.43 | -1.07 | |
| -1.24 | -1.27 | -0.98 | -0.82 | -0.54 | -0.53 | -0.57 | -0.42 | -0.28 | -0.09 | -0.16 | -0.29 | -0.81 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.